Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

169 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Alpha-particle radiotherapy with 211At-labeled monodisperse polymer particles, 211At-labeled IgG proteins, and free 211At in a murine intraperitoneal tumor model.
Larsen RH, Hoff P, Vergote IB, Bruland OS, Aas M, De Vos L, Nustad K. Larsen RH, et al. Gynecol Oncol. 1995 Apr;57(1):9-15. doi: 10.1006/gyno.1995.1093. Gynecol Oncol. 1995. PMID: 7705707
Inactivation of human osteosarcoma cells in vitro by 211At-TP-3 monoclonal antibody: comparison with astatine-211-labeled bovine serum albumin, free astatine-211 and external-beam X rays.
Larsen RH, Bruland OS, Hoff P, Alstad J, Lindmo T, Rofstad EK. Larsen RH, et al. Radiat Res. 1994 Aug;139(2):178-84. Radiat Res. 1994. PMID: 8052693
Cloning and sequencing of V genes from anti-osteosarcoma monoclonal antibodies TP-1 and TP-3: location of lysine residues and implications for radiolabeling.
Olafsen T, Bruland OS, Zalutsky MR, Sandlie I. Olafsen T, et al. Nucl Med Biol. 1995 Aug;22(6):765-71. doi: 10.1016/0969-8051(95)00014-o. Nucl Med Biol. 1995. PMID: 8535337
Cancer therapy with radiolabeled antibodies. An overview.
Bruland OS. Bruland OS. Acta Oncol. 1995;34(8):1085-94. doi: 10.3109/02841869509127235. Acta Oncol. 1995. PMID: 8608033 Review.
Predicting detectability in radioguided surgery: a study based on physical characterization of the probe and on tissue uptake ratios of 125I-, 153Sm- and 165Er-labelled radiopharmaceuticals.
Hassfjell SP, Skretting A, Bruland OS, Hoff P. Hassfjell SP, et al. Nucl Med Commun. 1998 Mar;19(3):207-17. Nucl Med Commun. 1998. PMID: 9625495
169 results
Jump to page
Feedback